Investor Presentation First Nine Months of 2022
159
Investor presentation First nine months of 2022
In the US, net prices have declined in the last five years
The US population by health insurance
coverage
7%
Novo NordiskⓇ
Insulin net prices¹ have declined
Net prices¹ across the full Novo Nordisk
portfolio² declined
Index
Index
150
150
124
116
100
47%
100
46%
333 million people
Uninsured
Private insurance schemes
Goverment insurance schemes
50
40
40
50
53
2016 2017 2018 2019 2020 2021
0
0
2016 2017 2018 2019 2020 2021
List price
Net price
-
List price Net price
¹Percentage change represents a sales weighted average list and net price for the respective calendar year compared to the sales weighted average list and net price for the prior year and is not reflective of the magnitude of
individual list price actions 2NN US Product Portfolio is inclusive of Diabetes, Obesity and Rare disease products
Government insurance schemes cover Medicare, Medicaid and public exchanges, some of these with high deductibles.
Source: Centres for Medicare and Medicaid services, office of the actuary, National Health expenditures ProjectionsView entire presentation